2023
DOI: 10.1155/2023/9245667
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Cuproptosis-Related Genes in Nonalcoholic Fatty Liver Disease

Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most prevalent hepatic pathology worldwide. However, the precise molecular mechanisms for NAFLD are still not sufficiently explained. Recently, a new mode of cell death (cuproptosis) is found. However, the relationship between NAFLD and cuproptosis remains unclear. We analyzed three public datasets (GSE89632, GSE130970, and GSE135251) to identify cuproptosis-related genes stably expressed in NAFLD. Then, we performed a series of bioinformatics analyses to explore… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…In the present study, we found a downward trend in SPG7, but there was no statistical difference, which may be caused by different species of samples or the heterogeneity of samples. Dihydrolipoamide dehydrogenase (DLD), as a cuproptosis-related gene [ 85 ], is associated with steatosis and plays an important role in nonalcoholic fatty liver disease [ 86 ]. DLD may serve as a therapeutic target for energy metabolism in AD [ 87 ].…”
Section: Discussionmentioning
confidence: 99%
“…In the present study, we found a downward trend in SPG7, but there was no statistical difference, which may be caused by different species of samples or the heterogeneity of samples. Dihydrolipoamide dehydrogenase (DLD), as a cuproptosis-related gene [ 85 ], is associated with steatosis and plays an important role in nonalcoholic fatty liver disease [ 86 ]. DLD may serve as a therapeutic target for energy metabolism in AD [ 87 ].…”
Section: Discussionmentioning
confidence: 99%